BHP Billiton Approve Expansion to Copper and Zinc Mine

BHP Billiton today announced it has approved its share of the capital expenditure required to expand mining and processing capacity at the Antamina copper and zinc mine in northern Peru.

Antamina is a joint venture between BHP Billiton (33.75%), Xstrata (33.75%), Teck Resources (22.5%) and Mitsubishi Corporation (10%). All four partners have approved their respective shares of the project's US$1,288 million capital budget (BHP Billiton share US$434.7 million).

The expansion project will increase the site's ore processing capacity by 38% to 130,000 tonnes per day. Higher mineral ore reserves previously reported in combination with the expanded processing capacity will result in a mine life extension of 6 years from 2023 until 2029. First production from the expansion is anticipated in late 2011.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BHP. (2019, March 18). BHP Billiton Approve Expansion to Copper and Zinc Mine. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=20247.

  • MLA

    BHP. "BHP Billiton Approve Expansion to Copper and Zinc Mine". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=20247>.

  • Chicago

    BHP. "BHP Billiton Approve Expansion to Copper and Zinc Mine". AZoM. https://www.azom.com/news.aspx?newsID=20247. (accessed April 25, 2024).

  • Harvard

    BHP. 2019. BHP Billiton Approve Expansion to Copper and Zinc Mine. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=20247.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.